4
Changes in Ownership
Voyager Therapeutics, Inc. Filed Acc 0001104659-22-101960
Options or other derivatives
- Chief Scientific Officer acquired 165,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Carter Todd Alfred · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2022-09-19 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +165,000 | $6.18 | 2032-09-19 | 165,000 | 165,000 | D |
Loading xslF345X03/tm2226340-2_4seq1.xml…